News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sensient Technologies Corporation Reports Results For The Quarter And Year Ended December 31, 2013


2/10/2014 8:43:09 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

MILWAUKEE--(BUSINESS WIRE)--Sensient Technologies Corporation (NYSE: SXT) reported diluted earnings per share of 56 cents in the fourth quarter, which includes restructuring costs of seven cents per share. As adjusted, to remove the impact of the restructuring costs, diluted earnings per share were 63 cents, a fourth quarter record and an increase of 15% over the 55 cents reported in the comparable period last year. Consolidated revenue was $351.1 million compared to $356.2 million in the fourth quarter of 2012. Operating income was $38.6 million as reported and included $5.7 million of pre-tax restructuring costs. Adjusted operating income increased 11.5% to $44.3 million compared to $39.7 million reported in last year’s fourth quarter. Foreign currency translation did not have a significant impact on revenue or operating income in the fourth quarter.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES